Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study.
Parasole R, Petruzziello F, Messina C, Barisone E, Pession A, Locatelli F, Micalizzi C, Cesaro S, Testi AM, De Matteo A, Varotto S, Berger M, Morello W, Menna G, Poggi V. Parasole R, et al. Among authors: petruzziello f. Leuk Lymphoma. 2015 Mar;56(3):650-5. doi: 10.3109/10428194.2014.927456. Epub 2014 Aug 4. Leuk Lymphoma. 2015. PMID: 24882262
Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients.
Miano M, Pistorio A, Putti MC, Dufour C, Messina C, Barisone E, Ziino O, Parasole R, Luciani M, Lo Nigro L, De Rossi G, Varotto S, Bertorello N, Petruzziello F, Calvillo M, Micalizzi C. Miano M, et al. Among authors: petruzziello f. Leuk Lymphoma. 2012 Sep;53(9):1693-8. doi: 10.3109/10428194.2012.663915. Epub 2012 Mar 13. Leuk Lymphoma. 2012. PMID: 22303898 Clinical Trial.
Single center experience on efficacy and safety of Aprepitant for preventing chemotherapy-induced nausea and vomiting (CINV) in pediatric Hodgkin Lymphoma.
Giagnuolo G, Buffardi S, Rossi F, Petruzziello F, Tortora C, Buffardi I, Marra N, Beneduce G, Menna G, Parasole R. Giagnuolo G, et al. Among authors: petruzziello f. PLoS One. 2019 Apr 12;14(4):e0215295. doi: 10.1371/journal.pone.0215295. eCollection 2019. PLoS One. 2019. PMID: 30978265 Free PMC article. Clinical Trial.
Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers.
Beneduce G, De Matteo A, Stellato P, Testi AM, Bertorello N, Colombini A, Putti MC, Rizzari C, Cesaro S, Cellini M, Barisone E, Petruzziello F, Menna G, Parasole R. Beneduce G, et al. Among authors: petruzziello f. Cancers (Basel). 2022 Jan 15;14(2):426. doi: 10.3390/cancers14020426. Cancers (Basel). 2022. PMID: 35053589 Free PMC article.
Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol.
Franca R, Rebora P, Bertorello N, Fagioli F, Conter V, Biondi A, Colombini A, Micalizzi C, Zecca M, Parasole R, Petruzziello F, Basso G, Putti MC, Locatelli F, d'Adamo P, Valsecchi MG, Decorti G, Rabusin M. Franca R, et al. Among authors: petruzziello f. Pharmacogenomics J. 2017 Jan;17(1):4-10. doi: 10.1038/tpj.2015.83. Epub 2015 Dec 8. Pharmacogenomics J. 2017. PMID: 26644204 Free article.
Brentuximab vedotin in combination with bendamustine in pediatric patients or young adults with relapsed or refractory Hodgkin lymphoma.
Vinti L, Pagliara D, Buffardi S, Di Ruscio V, Stocchi F, Mariggiò E, Parasole R, Di Matteo A, Petruzziello F, Paganelli V, De Vito R, Del Bufalo F, Strocchio L, Locatelli F. Vinti L, et al. Among authors: petruzziello f. Pediatr Blood Cancer. 2022 Apr;69(4):e29557. doi: 10.1002/pbc.29557. Epub 2022 Feb 2. Pediatr Blood Cancer. 2022. PMID: 35107876
39 results